Tower Research Capital LLC (TRC) - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$353,000
+828.9%
20,097
+418.9%
0.01%
+800.0%
Q2 2021$38,000
-25.5%
3,873
-19.0%
0.00%0.0%
Q1 2021$51,000
-12.1%
4,782
+16.6%
0.00%0.0%
Q3 2020$58,000
+314.3%
4,100
+139.3%
0.00%0.0%
Q2 2020$14,000
+366.7%
1,713
+213.2%
0.00%
Q3 2018$3,0000.0%547
+12.1%
0.00%
Q2 2018$3,000
-40.0%
488
-25.0%
0.00%
Q1 2018$5,000
+66.7%
651
+45.6%
0.00%
Q4 2017$3,000
+200.0%
447
+123.5%
0.00%
Q3 2017$1,0000.0%200
+100.0%
0.00%
Q2 2017$1,0000.0%1000.0%0.00%
Q1 2017$1,000
-50.0%
100
-66.7%
0.00%
Q4 2016$2,000
-90.5%
300
-71.3%
0.00%
-100.0%
Q3 2016$21,000
+600.0%
1,044
+248.0%
0.00%
Q2 2016$3,000
-66.7%
300
-70.5%
0.00%
-100.0%
Q1 2016$9,000
+800.0%
1,016
+1714.3%
0.00%
Q4 2015$1,0000.0%56
-23.3%
0.00%
Q3 2015$1,000
-87.5%
73
-75.7%
0.00%
-100.0%
Q2 2015$8,000
-74.2%
300
-75.0%
0.00%
-75.0%
Q1 2015$31,000
+106.7%
1,200
-26.5%
0.00%
+300.0%
Q4 2014$15,0001,6320.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders